Non-estrogenic approaches for the treatment of climacteric symptoms

References

• Seaman B. The Greatest Experiment ever Performed on Women: Exploding the Estrogen Myth. Iyperion. 2003
   Google Scholar
• Rothemberg C J. The rise and fall of estrogen therapy: The history of HRT, http://leda.law.harvard.edu/leda/data/711/Rothenberg05.pdf
   Google Scholar
• Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes?. Acta Obstet Gynecol Scand 1990; 69: 409–412
   PubMed Web of Science ®Google Scholar
• Thurston R C, Joffe H, Soares C N, Harlow B L. Physical activity and risk of vasomotor symptoms in women with and without a history of depression: results from the Harvard Study of Moods and Cycles. Menopause 2006; 13: 553–560
   PubMed Web of Science ®Google Scholar
• Greendale G A, Gold E B. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?. Am J Med 2005; 118(Suppl 12B)148–154
   PubMedGoogle Scholar
• Freedman R R. Current best treatment for hot flashes. Menopause Management 2006; 15: 20–25
   Google Scholar
• Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003; 44(Suppl 1)S67–S77
   PubMed Web of Science ®Google Scholar
• Newton K M, Reed S D, LaCroix A Z, Grothaus L C, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006; 145: 869–879
   PubMed Web of Science ®Google Scholar
• Pockaj B A, Gallagher J G, Loprinzi C L, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006; 24: 2836–2841
   PubMed Web of Science ®Google Scholar
• Frei-Kleiner S, Schaffner W, Rahlfs V W, Bodmer Ch, Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 2005; 51: 397–404
   PubMed Web of Science ®Google Scholar
• Jacobson J S, Troxel A B, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001; 19: 2739–2745
   PubMed Web of Science ®Google Scholar
• Cassidy A, Albertazzi P, Lise Nielsen I, et al. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 2006; 65: 76–92
   PubMed Web of Science ®Google Scholar
• Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 2005; 118(Suppl 12B)98–108
   PubMedGoogle Scholar
• Schiff I, Tulchinsky D, Cramer D, Rayan K J. Oral medroxyprogesterone in the treatment of postmenopausal symptom. JAMA 1980; 244: 1443–1445
   PubMed Web of Science ®Google Scholar
• Aslaksen K, Frankendal B. Effect of oral medroxyprogesterone acetate on menopausal symptoms in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 1982; 61: 423–428
   PubMed Web of Science ®Google Scholar
• Bertelli G, Venturini M, Del Mastro L, et al. Intramuscular depot medroxyprogesterone versus oral mergestrol for the control of postmenopausal hot flushes in breast cancer patients: a randomized study. Ann Oncol 2002; 13: 883–888
   PubMed Web of Science ®Google Scholar
• Loprizi C L, Michalak J C, Quella S K, et al. Mergestrol acetate for the prevention of hot flushes. N Engl J Med 1994; 331: 347–352
   PubMed Web of Science ®Google Scholar
• Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Leonetti H B, Longo S, Anasti J N. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999; 94: 225–228
   PubMed Web of Science ®Google Scholar
• Komesaroff P A, Black C V, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001; 4: 144–150
   PubMedGoogle Scholar
• Guttuso T J, Jr. Gabapentin's effects on hot flashes and hypothermia. Neurology 2000; 54: 2161–2163
   PubMed Web of Science ®Google Scholar
• Albertazzi P, Bottazzi M, Purdie D W. Gabapentin for the management of hot flushes: a case series. Menopause 2003; 10: 214–217
   PubMed Web of Science ®Google Scholar
• Guttuso T, Jr, Kurlan R, McDermott M P, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003; 101: 337–345
   PubMed Web of Science ®Google Scholar
• Pandya K J, Morrow G R, Roscoe J A, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 2005; 366: 818–824
   PubMed Web of Science ®Google Scholar
• Loprinzi C L, Kugler J W, Barton D L, et al. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol 2007; 25: 308–312
   PubMed Web of Science ®Google Scholar
• Reddy S Y, Warner H, Guttuso T, Jr, et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006; 108: 41–48
   PubMed Web of Science ®Google Scholar
• http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=433&within=Yes&keywords=venlafaxine
   Google Scholar
• Albertazzi P. Noradrenergic and serotonergic modulation to treat vasomotor symptoms. J Br Menopause Soc 2006; 12: 7–11
   PubMedGoogle Scholar
• Evans M L, Pritts E, Vittinghoff E, McClish K, Morgan K S, Jaffe R B. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005; 105: 161–166
   PubMed Web of Science ®Google Scholar
• Wyeth submits two new drug applications for women's health therapies. 06/26/2006 http://www.wyeth.com/news?nav=display&navTo=/wyeth_html/home/news/pressreleases/2006/1151332793019.html
   Google Scholar
• Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and fluoxetine in the treatment of post-menopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005; 12: 18–26
   PubMed Web of Science ®Google Scholar
• Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005; 23: 6919–6930
   PubMed Web of Science ®Google Scholar
• Loprinzi C L, Flynn P J, Carpenter L A, et al. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med 2005; 8: 924–930
   PubMedGoogle Scholar
• Gordon P R, Kerwin J P, Boesen K G, Senf J. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population. Menopause 2006; 13: 546–548
   PubMedGoogle Scholar